Form 6-K Inter & Co, Inc. For: Jun 03
United States Securities and Exchange Commission Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of June 2024 Commission File Number 132-02847 INTER & Co, INC. (Exact name of registrant as specified in its charter) N/A (Translation of Registrant’s executive offices) Av Barbacena, 1.219, 22nd Floor Belo Horizonte, Brazil, ZIP... (continue reading...)
Form 4 VERIZON COMMUNICATIONS For: May 30 Filed by: Silliman Craig L.
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 6-K Canadian Solar Inc. For: Jun 03
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of June 2024
Commission File Number: 001-33107
CANADIAN SOLAR INC.
545 Speedvale Avenue West, Guelph,
Ontario, Canada N1K 1E6
(Address of principal executive office)
Indicate by check mark... (continue reading...)
Form 6-K BioNTech SE For: Jun 03
UNITED STATESSECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a‑16 OR 15d‑16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 FOR THE MONTH OF JUNE 2024COMMISSION FILE NUMBER 001-39081 BioNTech SE(Translation of registrant’s name into English)An der Goldgrube 12D-55131 MainzGermany+49 6131-9084-0(Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual... (continue reading...)
Form D EF-0412 Fund III, a seri
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K MICROSTRATEGY Inc For: May 31
-
Form 424B3 Zeo Energy Corp.
-
Form NT 10-K PARK AEROSPACE CORP For: Mar 03
-
Form 8-A12B MEDTRONIC INC
-
Form 6-K Kenon Holdings Ltd. For: Jun 03
-
Form D JE-0424 Fund II, a serie
-
Form 8-K Sunnova Energy Internati For: Jun 03
-
Form 6-K WPP plc For: Jun 03
-
Form DEFA14A NEW YORK COMMUNITY BANCO
-
Form 8-K Neurogene Inc. For: Jun 03
-
Form 8-K Sensei Biotherapeutics, For: Jun 03
-
Form 6-K ZTO Express (Cayman) For: Jun 03
-
Form 8-K Liquidia Corp For: May 31
-
Form 8-K HUMANA INC For: Jun 03
-
Form 6-K Origin Agritech LTD For: Jun 03
-
Form 6-K Brainsway Ltd. For: Jun 03
-
Form 6-K MITSUBISHI UFJ FINANCIAL For: Jun 03
-
Form 6-K Hollysys Automation Tech For: Jun 03
-
Form D ZO-0513 Fund I, a series
-
Form D/A Spinecap Feeder Fund
-
Form 144 monday.com Ltd. Filed by: Zinman Eran
-
Form 8-K/A Avalo Therapeutics, Inc. For: Mar 27
-
Form 6-K Kingsoft Cloud Holdings For: Jun 03
-
Form D/A Marshall Wace Funds LP
-
Form 8-K uniQure N.V. For: Jun 03
-
Form D FI-0503 Fund I, a series
-
Form 425 Revelyst, Inc. Filed by: Vista Outdoor Inc.
-
Form 8-K Viatris Inc For: Jun 03
-
Form D/A Ronit Global Opportuniti
-
Form 8-K Century Therapeutics, For: Jun 03
-
Form 6-K SciSparc Ltd. For: Jun 03
-
Form 8-K BIO-PATH HOLDINGS, INC. For: Jun 03
-
Form 8-K Corbus Pharmaceuticals For: Jun 01
-
Form 8-K NEWS CORP For: May 31
-
Form 6-K FANHUA INC. For: Jun 03
-
Form 8-K HONEYWELL INTERNATIONAL For: Jun 03
-
Form 8-K SPRUCE BIOSCIENCES, INC. For: Jun 02
-
Form 6-K RedHill Biopharma Ltd. For: Jun 03
-
Form D/A Broad Peak Fund II Ltd.
-
Form 8-K JETBLUE AIRWAYS CORP For: Jun 03
-
Form 8-K EXACT SCIENCES CORP For: May 30
-
Form 6-K Immatics N.V. For: May 30
-
Form 8-K Zentalis Pharmaceuticals For: Jun 03
-
Form 8-K Galera Therapeutics, For: May 31
-
Form 6-K Colliers International For: Jun 03
-
Form SC 14D9/A Deciphera Pharmaceutical Filed by: Deciphera Pharmaceuticals, Inc.
-
Form SD Clene Inc.
-
Form 6-K Li Auto Inc. For: Jun 03
-
Form 6-K Osisko Development Corp. For: Jun 03
-
Form 6-K PEARSON PLC For: Jun 03
